Technology

Nevro

$177.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.47 (-0.26%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Nevro and other stocks, options, and ETFs commission-free!

About NVRO

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA. The listed name for NVRO is NEVRO CORP.

CEO
D. Keith Grossman
Employees
853
Headquarters
Redwood City, California
Founded
2006
Market Cap
6.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
722.09K
High Today
$180.45
Low Today
$177.25
Open Price
$177.51
Volume
584.01K
52 Week High
$188.14
52 Week Low
$65.05

Collections

NVRO Earnings

-$1.62
-$1.08
-$0.54
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 24, After Hours

You May Also Like

TMX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure